Serotonergic receptor binding in the brainstem in the Sudden Infant Death Syndrome in a high-risk population

Hannah C Kinney1, Rebecca D Folkerth2, Morgan E Nelson3

  • 1Department of Pathology, Boston Children's Hospital, Harvard School of Medicine, Boston, Massachusetts, United States of America.

Plos One
|September 10, 2025
PubMed

Insights

Sudden Infant Death Syndrome (SIDS) may stem from a brainstem serotonin defect affecting cardiorespiratory control. This defect, linked to preterm birth and stress, increases SIDS risk, particularly in disadvantaged populations.

Area of Science:

  • Neuroscience
  • Pediatrics
  • Public Health

Background:

  • Sudden Infant Death Syndrome (SIDS) disproportionately affects socioeconomically disadvantaged groups.
  • A potential cause of SIDS involves dysfunction in the brainstem's serotonin system, crucial for cardiorespiratory regulation and arousal.
  • Infant stress and premature birth may exacerbate this serotonergic deficit.

Purpose of the Study:

  • To investigate if reduced serotonin 1A (5-HT1A) receptor binding in the brainstem is associated with SIDS.
  • To explore the link between reduced 5-HT1A binding in SIDS infants and maternal substance use during pregnancy.
  • To examine the influence of socioeconomic factors on SIDS and brainstem serotonin levels.

Main Methods:

  • Receptor ligand autoradiography (3H-8-OH-DPAT) was used to measure 5-HT1A binding in brainstem nuclei.
  • Brainstem tissue was analyzed from infants who died of SIDS (n=14) and controls (n=10).
  • Data were correlated with prenatal exposures (smoking, drinking) and socioeconomic indicators (phone access, housing).

Main Results:

  • SIDS infants exhibited a brainstem serotonin defect, particularly pronounced in those born preterm.
  • Premature SIDS infants showed increased 5-HT1A binding compared to premature controls.
  • SIDS was significantly associated with poverty indicators like lack of a phone and overcrowded housing.

Conclusions:

  • The study supports a serotonin system defect in the brainstem as a key factor in SIDS pathogenesis.
  • Preterm birth and maternal/fetal stress may disrupt normal serotonergic system development, contributing to SIDS.
  • The findings highlight the complex interplay of biological, environmental, and socioeconomic factors in SIDS risk.

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.6K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
900
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
519
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
643
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
1.4K